Endovascular stenting for chronic femoro-iliac venous obstructive disease: Clinical efficacy and short-term outcomes - 14/12/19
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Abstract |
Purpose |
To report the clinical efficacy and mid-term outcomes of endovascular treatment in patients with chronic, symptomatic, post-thrombotic femoro-iliac venous obstruction.
Materials and methods |
Forty-two patients with post-thrombotic syndrome (PTS) presenting with femoro-iliac venous obstructive lesions treated in our institution by endovascular approach between March 2012 and October 2017 were retrospectively included. There were 27 women and 15 men with a mean age of 47.3±17 (SD) years (range: 22–86 years). Procedure included first venous recanalization, then pre-dilatation and self-expandable metallic stenting of the narrowed or occluded iliac and/or femoral veins. Severity of PTS and quality of life were assessed at baseline and 3 months after the intervention respectively, using Villalta score and Chronic Venous Insufficiency Questionnaire (CIVIQ-20) scale. Imaging follow-up evaluation of stent patency was based on the results of duplex Doppler ultrasound and computed tomography.
Results |
Immediate technical success was achieved in 41/42 (97.6%) patients, without any major complications. Primary patency, primary assisted patency and secondary patency at the end of the median imaging follow-up of 18.1 months (IQR, 9.7–34.4) were achieved in 29/42 (66.7%) patients, 33/42 (78.6%) patients and 37/42 (88.1%) patients, respectively. Median Villalta and CIVIQ-20 scores decreased from 14 (IQR, 10–19) and 57 (IQR, 39–72) at baseline, respectively, to 5 (IQR, 2–9) and 30 (IQR, 24–50) 3 months after the procedure, respectively (P<0.0001), showing significant decrease in the severity of PTS and improvement in the quality of life. The multiple linear regression model showed that both baseline Villalta and CIVIQ-20 scores ([95% CI: −7.80–3.79; P<0.0001] and [95% CI: 0.07–0.20; P<0.0001], respectively), age (95% CI: 0.04–0.19; P=0.002) and stenting expanse (95% CI: 0.97–5.65; P=0.006) were independent variables related to Villalta gain. Baseline Villalta (95% CI: 0.89–2.23; P<0.0001) was the single independent variable related to CIVIQ-20 gain.
Conclusion |
This study confirms the high clinical efficacy and favorable mid-term outcomes of endovascular stenting in patients with chronic symptomatic femoro-iliac venous obstructive lesions.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Post-thrombotic syndrome, Endovascular treatment, Self expandable metallic stents, Quality of life, Iliac vein
Mappa
Vol 101 - N° 1
P. 15-23 - Gennaio 2020 Ritorno al numero
Articolo precedente
- PICC management led by technicians: Establishment of a cooperation program with radiologists and evaluation of complications
- V. Chasseigne, A. Larbi, J. Goupil, I. Bouassida, M. Buisson, J.P. Beregi, J. Frandon
- Lesion detection on a combined “All-in-One” window compared to conventional window settings in thoracic oncology chest CT examinations
- A. Snoeckx, P. Vuylsteke, B.J.G. Broeckx, K. Carpentier, R. Corthouts, E.A. Luyckx, S. Nicolay, A.V. Hoyweghen, M.J. Spinhoven, J. Cant, P.M. Parizel
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.